Bruce Given, MD, discusses alpha-1 antitrypsin deficiency (AATD) treatment methods, including enzyme therapy and gene therapy, and the hope that advancements in replacement therapy will improve treatments...
Co-Chair Daniel Einhorn, MD, FACP, FACE, talks with fellow Co-Chair Edward Shahady, MD, FAAFP, ABCL about the early results of SGLT2 inhibitors and the cardiovascular benefits and cardiac outcomes.
In this video, MeiLan K. Han, MD, MS, explains her decision-making process for determining the risk/reward of performing imaging for the identification of COPD, calling it a "delicate balance." It is a...
